Report
Valens Research

AGN - Embedded Expectations Analysis - 2018 09 14

Allergan plc (AGN:USA) currently trades well below corporate averages relative to UAFRS-based (Uniform) Earnings, with an 8.3x Uniform P/E, implying bearish expectations for the firm. However, management is confident in their R&D productivity and market positioning

Specifically, management generated an excitement marker when saying that they have invested in buying out distributors for CoolSculpting to allow them to go direct in several key markets. Furthermore, management is confident in their R&D productivity, and that people will walk away from the Medical Aesthetics Day excited about the market and the company's position in the market. Moreover, management is also confident that Abicipar has a positive risk-reward profile, and in their positioning given the bifurcation of the vision market
Underlying
Allergan plc

Provider
Valens Research
Valens Research

In 2009, just as the dust was settling from the last major equity and credit market crises, we launched a boutique research firm with the intention of breaking Wall Street’s biases and broken incentives:

  • GAAP and IFRS have failed to provide rules for reliable financial statement reporting
  • Stock analyst recommendations are not grounded in disciplined financial analysis
  • Credit agencies have been set up to grossly fail in their responsibilities to investors and the public markets
  • Utter lack of willingness of major research firms to employ the the most advanced forensic analysis available

We sought to provide investors and company analysts with a source of information that changed all that.
Many years later, our business model remains because little has changed on Wall Street.

  • Corporate credit ratings remain years behind the fundamental underpinnings of company performance
  • Stock analysts continue to make recommendations with deeply inherent biases
  • Research firms have failed to break down the walls between credit, equity, and macroeconomic research
  • The governing accounting bodies have created more leeway for mis-estimates and mis-classifications as financials have become unwieldy and overwhelming

The integrity of Valens Research is founded in our disciplined processes and analytics. No “star” analysts. No corporate advisory relationships. No-nonsense opinions and recommendations.

Analysts
Valens Research

Other Reports on these Companies
Other Reports from Valens Research

ResearchPool Subscriptions

Get the most out of your insights

Get in touch